British Patient Capital logo

British Patient Capital

Europe, Sheffield, United Kingdom, Sheffield

Description

British Patient Capital invests in a diversified portfolio of best-in-class venture and growth capital funds, and start ups.

Investor Profile

British Patient Capital has made 36 investments, with 13 in the past 12 months and 22% as lead.

Stage Focus

  • Series B (36%)
  • Series C (22%)
  • Series A (17%)
  • Series Unknown (11%)
  • Series D (8%)
  • Series E (3%)
  • Series F (3%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Artificial Intelligence (Ai)
  • Life Science
  • Compliance
  • Insurtech
  • Risk Management
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does British Patient Capital frequently co-invest with?

Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 4
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 3
ABN AMRO Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 3
Molten Ventures
Europe, England, United Kingdom, London
Co-Investments: 3
Cambridge Innovation Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 3
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
IP Group
Europe, England, United Kingdom, London
Co-Investments: 4
Epidarex Capital
North America, Maryland, United States, Bethesda
Co-Investments: 3
IQ Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 4
Oxford Science Enterprises
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 5

Which angels does British Patient Capital often collaborate with?

JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by British Patient Capital?

Maxion Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Maxion Therapeutics helps in learning transformative therapies.

Information TechnologyTherapeutics
Series AMar 17, 2025
Amount Raised: $75,016,620
Quantexa

London, England, United Kingdom

Quantexa is a decision intelligence platform that helps public and private companies uncover hidden risks and identify new opportunities.

AnalyticsArtificial Intelligence (AI)ComplianceInsurTechRisk Management
Series FMar 5, 2025
Amount Raised: $175,000,000
Cambridge GaN Devices

Cambridge, Cambridgeshire, United Kingdom

Cambridge GaN Devices is a semiconductor company focused on developing GaN power devices aimed at creating greener electronics.

ElectronicsManufacturingSemiconductor
Series CFeb 18, 2025
Amount Raised: $32,000,000
Tenpoint Therapeutics

Camborne, Cornwall, United Kingdom

Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

BiotechnologyProduct Research
Series UnknownDec 11, 2024
Tokamak Energy

Oxford, Oxfordshire, United Kingdom

Tokamak Energy is a private company developing and accelerating the development of fusion power.

EnergyEnvironmental ConsultingEnvironmental EngineeringRenewable Energy
Series UnknownNov 19, 2024
Amount Raised: $125,000,000
Nuclera

Cambridge, Cambridgeshire, United Kingdom

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

BiotechnologyLife SciencePharmaceutical
Series COct 15, 2024
Amount Raised: $75,000,000
Purespring Therapeutics

London, England, United Kingdom

Purespring Therapeutics is a gene therapy company that provides treatments for different kidney diseases.

BiotechnologyMedicalTherapeutics
Series BOct 9, 2024
Amount Raised: $104,529,935
Form3

London, England, United Kingdom

Form3 is a cloud native payments-as-a-service platform that designs, builds, and manages payment technology.

BankingFinancial ServicesFinTechMobile PaymentsPayments
Series CSep 10, 2024
Amount Raised: $60,166,976
Epsilogen

London, England, United Kingdom

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

BiopharmaBiotechnologyGeneticsLife ScienceOncologyTherapeutics
Series BSep 9, 2024
Amount Raised: $16,338,566
Microbiotica

Cambridge, Cambridgeshire, United Kingdom

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

BiotechnologyHealth CareTherapeutics
Series UnknownAug 27, 2024